ATE315577T1 - Neue aminosäuresequenzen, deren kodierende dns, antikörper dagegen und deren verwendungen - Google Patents

Neue aminosäuresequenzen, deren kodierende dns, antikörper dagegen und deren verwendungen

Info

Publication number
ATE315577T1
ATE315577T1 AT99954318T AT99954318T ATE315577T1 AT E315577 T1 ATE315577 T1 AT E315577T1 AT 99954318 T AT99954318 T AT 99954318T AT 99954318 T AT99954318 T AT 99954318T AT E315577 T1 ATE315577 T1 AT E315577T1
Authority
AT
Austria
Prior art keywords
amino acid
acid sequences
antibodies against
coding dna
new amino
Prior art date
Application number
AT99954318T
Other languages
English (en)
Inventor
Yaakov Naparstek
Rina Ulmansky
Yechezkel Kashi
Original Assignee
Hadasit Med Res Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hadasit Med Res Service filed Critical Hadasit Med Res Service
Application granted granted Critical
Publication of ATE315577T1 publication Critical patent/ATE315577T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AT99954318T 1998-11-05 1999-11-04 Neue aminosäuresequenzen, deren kodierende dns, antikörper dagegen und deren verwendungen ATE315577T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10721398P 1998-11-05 1998-11-05

Publications (1)

Publication Number Publication Date
ATE315577T1 true ATE315577T1 (de) 2006-02-15

Family

ID=22315463

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99954318T ATE315577T1 (de) 1998-11-05 1999-11-04 Neue aminosäuresequenzen, deren kodierende dns, antikörper dagegen und deren verwendungen

Country Status (11)

Country Link
US (2) US6770281B2 (de)
EP (1) EP1127064B1 (de)
JP (1) JP4717213B2 (de)
AT (1) ATE315577T1 (de)
AU (1) AU759303B2 (de)
CA (1) CA2350340C (de)
DE (1) DE69929454T2 (de)
DK (1) DK1127064T3 (de)
ES (1) ES2257082T3 (de)
IL (1) IL142709A0 (de)
WO (1) WO2000027870A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8158125B2 (en) 1998-11-05 2012-04-17 Hadasit Medical Research Services & Development Ltd. B-cell epitope peptides of HSP 65, novel amino acid sequences, DNA encoding the amino acid sequences of said peptides, antibodies directed against said peptides and different uses thereof in the treatment of inflammatory and autoimmune diseases
US7488476B2 (en) * 1998-11-05 2009-02-10 Hadasit Medical Research Services & Development Ltd. B-cell epitope peptides of HSP 65, DNA encoding said peptides, antibodies directed against said peptides and the different uses thereof in the treatment of inflammatory and autoimmune diseases
GB0028122D0 (en) * 2000-11-17 2001-01-03 St Georges Entpr Ltd Method
EP2157101B1 (de) 2002-01-31 2014-09-24 Andromeda Bio Tech Ltd. HSP-Peptide und Analoga zur Modulation von Immunantworten mittels antigenpräsentierenden Zellen
AU2003230181A1 (en) 2002-05-21 2003-12-02 Yeda Research And Development Co. Ltd. Dna vaccines encoding heat shock proteins
EP1687423A4 (de) * 2003-11-24 2007-04-18 Yeda Res & Dev Für hsp60-peptidfragmente codierende dna-impfstoffe zur behandlung von autoimmunkrankheiten
WO2006072946A2 (en) * 2005-01-04 2006-07-13 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Hsp60, hsp60 peptides and t cell vaccines for immunomodulation
US9078843B2 (en) 2005-09-22 2015-07-14 Irun R. Cohen Immunogenic fragments of T-cell receptor constant domains and peptides derived therefrom
RU2011143776A (ru) * 2009-03-30 2013-05-10 Протаб Лтд. Белок, ассоциированный с аденилатциклазой (сар1) и применение его в качестве мишени для иммуномодуляции
EP3366308A1 (de) * 2009-09-06 2018-08-29 Protab Ltd. Für das aus hsp65 gewonnene peptid 6 spezifische humanisierte antikörper und verwendungen davon

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780034A (en) * 1989-03-14 1998-07-14 Yeda Research And Development Co. Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus using heat shock protein determinents
US5114844A (en) * 1989-03-14 1992-05-19 Yeda Research And Development Co., Ltd. Diagnosis and treatment of insulin dependent diabetes mellitus
EP0751957B1 (de) * 1994-03-21 2004-02-25 Rijksuniversiteit Utrecht Peptidfragmente von mikrobiellen stressproteinen und daraus hergestellte pharmazeutische zusammensetzungen für die behandlung und vorbeugung von entzündungserkrankungen
GB9419553D0 (en) * 1994-09-27 1994-11-16 Univ Bristol Polypeptides and their use in the treatment of auto-immune disease
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections

Also Published As

Publication number Publication date
EP1127064A1 (de) 2001-08-29
AU759303B2 (en) 2003-04-10
DE69929454D1 (de) 2006-04-06
DE69929454T2 (de) 2006-09-28
DK1127064T3 (da) 2006-05-22
JP2002530055A (ja) 2002-09-17
US6770281B2 (en) 2004-08-03
US7247305B2 (en) 2007-07-24
ES2257082T3 (es) 2006-07-16
US20020150586A1 (en) 2002-10-17
US20050096285A1 (en) 2005-05-05
JP4717213B2 (ja) 2011-07-06
WO2000027870A1 (en) 2000-05-18
EP1127064B1 (de) 2006-01-11
IL142709A0 (en) 2002-03-10
CA2350340A1 (en) 2000-05-18
CA2350340C (en) 2011-08-09
AU1072400A (en) 2000-05-29

Similar Documents

Publication Publication Date Title
DE69528061D1 (de) Gereinigte polyporus laccasen und dafür kodierende nukleinsäuren
DK1015587T3 (da) DcR3 polypeptid, en TNFR-homolog
AU4778101A (en) Novel polypeptides, and nucleic acids encoding the same
DE69834852D1 (de) NL3 TIE Rezeptortyrosinekinase Ligandhomologe
DE69929454D1 (de) Neue aminosäuresequenzen, deren kodierende dns, antikörper dagegen und deren verwendungen
DK2256205T3 (da) Porphorymonas gingivalis-polypeptider og -polynukleotider
DK1114156T3 (da) Transformerende vækstfaktor Beta-9 (ZTGFSS9) fra pattedyr
WO1999000407A3 (en) Improved bacillus thuringiensis toxin
ATE362769T1 (de) Lineare kationische peptide mit fungizider wirksamkeit
CO4480058A1 (es) Genes codificantes y procedimiento de expresion de una nueva enzima: ftalil amidasa
GB9416536D0 (en) Orphan receptor
DE69623635D1 (de) Mu-opioidligande: agonisten und antagonisten
DE69739071D1 (de) Menschliche tak1 und für diese kodierende dna
EA200100314A1 (ru) Пептидные фрагменты холерного экзотоксина в или энтеротоксина в в качестве адъювантов вакцины
ATE304553T1 (de) Polypeptide mit wasserkanalaktivität und dna sequenzen
WO2001049714A3 (en) Nope polypeptides, encoding nucleic acids and methods of use
AU1993201A (en) Nucleic acid sequences of hyperplasia and tumours of the thyroid
LV12722A (lv) Prv-1 gene and the use thereof
SE9402253D0 (sv) Process
ATE432985T1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
ATE438660T1 (de) Neue menschliche g-protein gekoppelten rezeptoren und dafür kodierende polynucleotide
NZ606260A (en) Novel polypeptides involved in immune response
AU4956901A (en) Novel human 7tm proteins and polynucleotides encoding the same
ATE409747T1 (de) Mit wt1 interagierendes protein, wtip
DE60128570D1 (de) Neuartige proteine und deren dna

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1127064

Country of ref document: EP